Chundong Gu

2.0k total citations
51 papers, 1.0k citations indexed

About

Chundong Gu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chundong Gu has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Chundong Gu's work include RNA modifications and cancer (17 papers), Lung Cancer Treatments and Mutations (12 papers) and Cancer-related molecular mechanisms research (10 papers). Chundong Gu is often cited by papers focused on RNA modifications and cancer (17 papers), Lung Cancer Treatments and Mutations (12 papers) and Cancer-related molecular mechanisms research (10 papers). Chundong Gu collaborates with scholars based in China, Japan and United States. Chundong Gu's co-authors include Tsunehiro Oyama, Kosei Yasumoto, Fengzhou Li, Toshihiro Osaki, Lei Fang, Shilei Zhao, Hidetaka Uramoto, Kenji Sugio, Mitsuhiro Takenoyama and Hidehiko Shimokawa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Chundong Gu

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chundong Gu China 20 535 357 299 238 115 51 1.0k
Runsen Jin China 19 520 1.0× 456 1.3× 410 1.4× 259 1.1× 150 1.3× 54 1.1k
Wenhua Lang United States 17 784 1.5× 304 0.9× 374 1.3× 257 1.1× 119 1.0× 28 1.3k
Ken Suzawa Japan 19 483 0.9× 565 1.6× 504 1.7× 282 1.2× 124 1.1× 80 1.1k
Jiliang Shen China 13 644 1.2× 201 0.6× 259 0.9× 353 1.5× 120 1.0× 29 1.1k
Zuli Yang China 18 442 0.8× 297 0.8× 290 1.0× 224 0.9× 176 1.5× 44 963
Qingjiang Hu Japan 19 445 0.8× 190 0.5× 321 1.1× 288 1.2× 164 1.4× 79 945
Akihiko Miyanaga Japan 18 638 1.2× 426 1.2× 446 1.5× 295 1.2× 52 0.5× 75 1.1k
Guoren Zhou China 19 561 1.0× 346 1.0× 236 0.8× 298 1.3× 164 1.4× 88 1.0k
Shazli N. Malik United States 13 801 1.5× 400 1.1× 411 1.4× 232 1.0× 130 1.1× 16 1.2k
Qi-Shan Dai China 21 770 1.4× 291 0.8× 289 1.0× 426 1.8× 121 1.1× 39 1.2k

Countries citing papers authored by Chundong Gu

Since Specialization
Citations

This map shows the geographic impact of Chundong Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chundong Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chundong Gu more than expected).

Fields of papers citing papers by Chundong Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chundong Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chundong Gu. The network helps show where Chundong Gu may publish in the future.

Co-authorship network of co-authors of Chundong Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Chundong Gu. A scholar is included among the top collaborators of Chundong Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chundong Gu. Chundong Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhuoshi, Shiqing Wang, Shilei Zhao, et al.. (2025). PGC-1α Promotes NSCLC Progression via FOXM1 Interaction and MUC1 Upregulation. Cancer Biotherapy and Radiopharmaceuticals. 40(8). 567–579.
2.
Han, Li, Zhe Piao, Haili Qian, et al.. (2024). Metastasis‐associated 1 localizes to the sarcomeric Z‐disc and is implicated in skeletal muscle pathology. Cytoskeleton. 81(9-10). 427–435.
3.
Zhang, Yixiang, et al.. (2024). Genomic heterogeneity of multiple synchronous lung cancers in Chinese population. Cancer Medicine. 13(2). e6928–e6928. 2 indexed citations
4.
Li, Zhuoshi, Shiqing Wang, Tao Guo, et al.. (2024). MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4. Cell Death Discovery. 10(1). 494–494. 2 indexed citations
5.
6.
Wang, Peng, et al.. (2023). UPF1 regulates FOXO1 protein expression by promoting PBK transcription in non-small cell lung cancer. Biochemical and Biophysical Research Communications. 666. 10–20. 2 indexed citations
7.
Fang, Lei, Huan Qi, Peng Wang, et al.. (2022). UPF1 increases amino acid levels and promotes cell proliferation in lung adenocarcinoma via the eIF2α-ATF4 axis. Journal of Zhejiang University SCIENCE B. 23(10). 863–875. 5 indexed citations
8.
Yang, Mengying, Chunli Wang, Wenjun Fan, et al.. (2022). VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function. Frontiers in Oncology. 12. 887035–887035. 2 indexed citations
9.
Wang, Ling, et al.. (2022). Thymoma (World Health Organization Type AB) in multiple endocrine neoplasia type 1: a case report. Journal of Surgical Case Reports. 2022(7). rjac290–rjac290. 1 indexed citations
10.
Zhao, Shilei, Xin Guo, Kenichi Mizutani, et al.. (2021). Overexpression of Teashirt Homolog 2 suppresses cell proliferation and predicts the favorable survival of Lung Adenocarcinoma. International Journal of Medical Sciences. 18(9). 1980–1989. 4 indexed citations
11.
12.
Liu, Baodong & Chundong Gu. (2020). Expert consensus workshop report: Guidelines for preoperative assisted localization of small pulmonary nodules. Journal of Cancer Research and Therapeutics. 16(5). 967–967. 25 indexed citations
13.
Zhao, Shilei, Xin Guo, Makoto Taniguchi, et al.. (2020). Detection of Mediastinal Lymph Node Metastases Using Indocyanine Green (ICG) Fluorescence Imaging in an Orthotopic Implantation Model. Anticancer Research. 40(4). 1875–1882. 4 indexed citations
14.
Cui, Yanwei, Lei Zhao, Shilei Zhao, et al.. (2019). MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9. Human Cell. 32(3). 326–333. 16 indexed citations
15.
Wang, Peng, Ying Gong, Tao Guo, et al.. (2019). Activation of Aurora A kinase increases YAP stability via blockage of autophagy. Cell Death and Disease. 10(6). 432–432. 52 indexed citations
16.
Zhong, Wen‐Zhao, Yi‐Long Wu, Chundong Gu, et al.. (2018). CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study. Annals of Oncology. 29. viii738–viii738. 7 indexed citations
17.
Guo, Tao, Jing Kong, Yang Liu, et al.. (2017). Transcriptional activation of NANOG by YBX1 promotes lung cancer stem-like properties and metastasis. Biochemical and Biophysical Research Communications. 487(1). 153–159. 29 indexed citations
18.
Zhao, Shilei, Wei Guo, Jinxiu Li, et al.. (2016). High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma. OncoTargets and Therapy. 9. 2683–2683. 19 indexed citations
19.
Zhao, Shilei, Tao Guo, Jinxiu Li, et al.. (2015). Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification. OncoTargets and Therapy. 8. 3143–3143. 15 indexed citations
20.
Wei, Shaohua, et al.. (2014). Clinical research of preperitoneal drainage after endoscopic totally extraperitoneal inguinal hernia repair. Hernia. 19(5). 789–794. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Runsen Jin Breakdown of academic impact, for papers by Wenhua Lang Breakdown of academic impact, for papers by Ken Suzawa Breakdown of academic impact, for papers by Jiliang Shen Breakdown of academic impact, for papers by Zuli Yang Breakdown of academic impact, for papers by Qingjiang Hu Breakdown of academic impact, for papers by Akihiko Miyanaga Breakdown of academic impact, for papers by Guoren Zhou Breakdown of academic impact, for papers by Shazli N. Malik Breakdown of academic impact, for papers by Qi-Shan Dai
Rankless by CCL
2026